SPCC (Sharing Progress in Cancer Care) shared a post on LinkedIn:
“Recent progress in radioligand therapy is rapidly enhancing targeting precision and offering new hope for patients with advanced or treatment-resistant malignancies.
To explore how translational research is bringing these innovations into clinical use, Antoine Leimgruber will lead a dedicated webinar on Tuesday 24 February at 18:00 CET.
Alongside experts Anne-Laure Giraudet, Niklaus Schaefer, and Saverio Braccini, we will discuss the current offerings of modern cancer centres and the most promising radionuclides expected to emerge in the coming years.
You can find the full programme and register via the link.
This session is part of the SPCC Sustaining Corporate Programme 2026.
Sharing Progress in Cancer Care wishes to extend appreciation to its Sustaining Companies for providing unrestricted educational support to the following webinar. Companies have no control over the session content or speakers.”
More posts about SPCC.